Calidi Biotherapeutics, Inc. (CLDI)
Stock-Based Compensation
$157.00K
Quarterly · Period ending: · USD
CLDI Stock-Based Compensation
Latest reported$157.00Kperiod ending
Latest reported$157.00Kperiod ending
CLDI Quarterly Stock-Based Comp ($0.00 → $157.00K)
Quarterly stock-based compensation
High-resolution chart · PNG
CLDI stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 157,000 | |
| 231,000 | |
| 450,000 | |
| 529,000 | |
| 522,000 | |
| 607,000 | |
| 626,000 | |
| 692,000 | |
| 751,000 | |
| 888,000 | |
| 1,186,000 | |
| 1,109,000 | |
| 1,080,000 | |
| 1,434,000 | |
| 1,058,000 | |
| 0 | |
| 936,000 | |
| 1,466,000 | |
| 412,000 | |
| 0 |